Definitive Contract 75N91023C00056

Award Date 9/11/23
Potential Completion Date 9/10/25
Potential Value $2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20170, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023....
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This firm fixed price contract for $454,999 was awarded by the National Institutes of Health National Cancer Institute to Pathodynamics LLC, a minority-owned small disadvantaged business, to advance Topic 438 from the agency's Small Business Innovation Research program solicitation. Topic 438 sought technologies to aid community providers in understanding cancer patients' genomic test results. The contract supports the development of applications to help oncology practitioners interpret...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $2 million firm fixed price definitive contract to Carina Medical LLC as a total small business set aside. The contract is for Fiscal Year 2023 Small Business Innovation Research Topic 402 Phase II efforts to enhance the performance of artificial intelligence for lymph node detection, segmentation and measurements in multi-modality medical imaging, and to develop additional...
This federal contract award, with ID 75N91021C00050, was made by the National Cancer Institute (NCI) to Pieces Technologies Inc., a small business, for a Firm Fixed Price SBIR Phase I research contract valued at $400,000.00. The contract is focused on "Screening for Social Determinants of Health and Interventions to Improve Outcomes in Cancer Patients". This award is part of the NCI's Small Business Innovation Research (SBIR) program, which aims to stimulate technological innovation...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.5 million delivery order contract to Leidos Biomedical Research Inc. to provide manufacturing of tumor-penetrating microparticles suitable for human use. The contract runs from September 15, 2023 through September 14, 2028 and utilizes a cost plus fixed fee pricing structure. Performance will take place in Fort Detrick, Maryland. No applicable subcontractors were identified.</p>
The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS - NIH) awarded a $1,998,445 Definitive Contract to Impact Business Information Solutions, Inc. of Princeton, New Jersey. The contract is for the provision of AUTOMATED DEIDENTIFICATION OF PATHOLOGY AND RADIOLOGY DATA services over a two-year period from August 15, 2023 through August 14, 2025. The pricing structure is Firm Fixed Price. The contract was set aside for Total Small Business. No...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of &quot;Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning&quot; as described in the original solicitation. This Phase I SBIR contract has a period of performance from...

The National Institutes of Health National Cancer Institute awarded a $2,047,174 firm fixed price, total small business set aside definitive contract to Pistevo Decision LLC of Herndon, Virginia. The contract period of performance is from September 11, 2023 through September 10, 2025. Under Topic 423 (Phase II), Pistevo Decision LLC will provide an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients for the Department of Health and Human Services National Institutes of Health National Cancer Institute.

Generated 11/28/23, 9:44 PM